Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dialysis01:27

Dialysis

277
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
277
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

133
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
133
Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

5.5K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
5.5K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

153
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
153

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Expression and Characterization of a Recombinant Laccase with Alkalistable and Thermostable Properties from Streptomyces griseorubens JSD-1.

Applied biochemistry and biotechnology·2015
Same author

Herb-Partitioned Moxibustion and the miRNAs Related to Crohn's Disease: A Study Based on Rat Models.

Evidence-based complementary and alternative medicine : eCAM·2015
Same author

Bioactive carbazole alkaloids from the stems of Clausena lansium.

Fitoterapia·2015
Same author

Clauemarazoles A-G, seven carbazole alkaloids from the stems of Clausena emarginata.

Fitoterapia·2015
Same author

Scalable and DiI-compatible optical clearance of the mammalian brain.

Frontiers in neuroanatomy·2015
Same author

FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca(2+)/CREB pathway.

Aging cell·2015

相关实验视频

Updated: Jun 14, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

525

基于CAR治疗脏疾病的当前进展.

Dan Zhang1, Dong Sun1,2,3

  • 1Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Frontiers in immunology
|September 5, 2024
PubMed
概括

化学抗原受体 (CAR) T细胞疗法在治疗免疫媒介脏疾病方面表现有前途. 这种方法使T细胞向和抑制自身免疫细胞,为耐火病例提供了新的希望.

科学领域:

  • 免疫学 免疫学 免疫学
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 细胞疗法细胞疗法

背景情况:

  • 免疫媒介性脏疾病存在挑战,因为一些患者的治疗反应不佳.
  • 现有的治疗方法对于耐火性病病例是不够的.
  • 工程T细胞为脏疾病提供了一种新的治疗途径.

研究的目的:

  • 审查化学抗原受体 (CAR) T细胞治疗免疫媒介脏疾病的进展.
  • 突出CAR T细胞治疗在基础,转化和临床研究中的潜力.
  • 探索CAR T细胞在向自身反应性免疫细胞和缓解自身免疫性病中的应用.

主要方法:

  • 基因修饰T细胞以表达仿制抗原受体 (CARs).
  • 准自身反应性免疫细胞,包括B细胞和血细胞.
  • 利用效应细胞和调节性T细胞 (Tregs) 进行自身免疫特异性治疗.

主要成果:

  • 卡尔T细胞疗法能够精确准脏病相关的自身免疫细胞.
  • 工程T细胞可以迁移到自身免疫的部位,增殖,并发挥抑制功能.
  • 这种方法为缓解脏自身免疫表现提供了一种新的策略.
关键词:
的T淋巴细胞.自身免疫性疾病 自身免疫性疾病细胞免疫疗法细胞免疫疗法仿制性抗原受体T细胞疗法脏疾病 脏疾病

更多相关视频

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K

相关实验视频

Last Updated: Jun 14, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

525
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K

结论:

  • 卡尔T细胞疗法代表了治疗免疫媒介脏疾病的前沿.
  • 转基因T细胞提供了一种减少自身炎症事件的新机制.
  • 需要进一步的研究和临床研究才能充分实现CAR T细胞干预的治疗潜力.